Definitive radiation therapy for prostatic carcinoma: Mayo clinic experience

Area of Science:

• Oncology
• Radiation Oncology

Background:

• Primary radiation therapy is a standard treatment for clinically localized prostate cancer.
• Long-term outcomes and prognostic factors require continued investigation.

Purpose of the Study:

• To evaluate the long-term efficacy and safety of primary radiation therapy for localized prostate cancer.
• To identify prognostic factors influencing survival and disease progression.

Main Methods:

• Retrospective analysis of 147 patients treated with primary radiation therapy between 1964 and 1973.
• Evaluation of overall survival, disease-free survival, and progression-free rates at 5 years.
• Statistical analysis of the association between tumor grade, tumor stage, and patient outcomes.

Main Results:

• At 5 years, the overall survival rate was 80%, and disease-free survival was 63%.
• Over 70% of patients remained progression-free at 5 years, with an 86% local control rate.
• Tumor grade strongly correlated with survival (p<0.001) and disease-free interval (p<0.002). Tumor stage showed a significant relationship with progression (p≈0.01).

Conclusions:

• Primary radiation therapy is an effective and safe treatment for localized prostate cancer, yielding high long-term survival and local control rates.
• Tumor grade is a critical prognostic factor for patient survival and disease progression.
• Post-treatment biopsy is recommended only for positive results in cases of increased induration; otherwise, it is not predictive of cancer course.